Michael Shafique

4PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 26, 2026
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.

Misty D Shields, Katherine G Minton, Hilal Ozakinci

|Apr 06, 2021
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.

Michael R Shafique, Terrence L Fisher, Elizabeth E Evans

|Aug 15, 2019
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.

Jhanelle E Gray, Andreas Saltos, Tawee Tanvetyanon

|Jan 19, 2019
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer.

Michael Shafique, Tawee Tanvetyanon

Pageof 1

Frequent Collaborators

1 joint publications

John E Leonard

1 joint publications

Joseph T Beck

1 joint publications

Megan A Baumgart

1 joint publications

Nagashree Seetharamu